FTC breast enhancement case
This article was originally published in The Tan Sheet
Executive Summary
J. Michael Ernest, PhD, Isis Breast Enhancement System developer, agrees to settle FTC charges he made deceptive statements in print, radio, TV, Internet ads for the supplement/topical cream combo, commission says Jan. 22. Proposed stipulated final order requires Ernest to "have competent and reliable scientific evidence" before making any claims about Isis, other products. Settlement follows recent case brought by FTC against Isis marketer Vital Dynamics, which was settled in December (1"The Tan Sheet" Jan. 6, 2003, p. 19)...
You may also be interested in...
Isis Breast Enhancement System Safety, Efficacy Questioned By FTC
Vital Dynamics promoted its Isis Breast Enhancement System as free of side effects after receiving "hundreds of reports of negative side effects," according to a Federal Trade Commission complaint
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.